Sunshine Biopharma (SBFM) Gross Profit Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFM) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | -29.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.10% |
| Mar 31, 2026 | -20.12% |
| Dec 31, 2025 | -2.08% |
| Sep 30, 2025 | 7.24% |
| Jun 30, 2025 | 45.27% |
| Mar 31, 2025 | 15.97% |
| Dec 31, 2024 | 20.44% |
| Sep 30, 2024 | 44.01% |
| Jun 30, 2024 | 20.66% |
| Mar 31, 2024 | 28.78% |
| Dec 31, 2023 | 72.22% |
| Sep 30, 2023 | 2,869.42% |
| Jun 30, 2023 | 2,482.18% |
| Mar 31, 2023 | 2,811.02% |
| Dec 31, 2022 | 6,157.61% |
| Sep 30, 2022 | 117.12% |
| Jun 30, 2022 | 120.10% |
| Mar 31, 2022 | 191.58% |
| Dec 31, 2021 | 35.78% |
| Sep 30, 2021 | 185.57% |